Latest Headlines
-
Solesis, Parent Company of Charter Medical, to Expand Single-use Manufacturing Capabilities into Costa Rica
2/2/2024
The site will expand capabilities to enable development in the fast-growing cardiovascular and advanced therapy markets.
-
Cleanroom Leader AES Clean Technology Announces New Vice President Of Construction
2/1/2024
A leading provider of high-performance cleanroom facilities, AES Clean Technology, has announced the appointment of John Costalas to its senior leadership team as Vice President of Construction.
-
AustinPx Partners With Microsize On KinetiSol® Technology
1/31/2024
AustinPx, a contract development and manufacturing organization (CDMO) specializing in bioavailability enhancement of orally delivered small molecule drug candidates, and Microsize, a leading active pharmaceutical ingredient enhancement CDMO, today announced the strategic partnership to accelerate the commercial application of AustinPx’s KinetiSol® Technology platform. The collaboration will enable AustinPx’s clients to manufacture their late-phase clinical and commercial KinetiSol drug product intermediate at Microsize’s purpose built, FDA-inspected facility.
-
Kite Receives U.S. FDA Approval of Manufacturing Process Change Resulting in Reduced Median Turnaround Time for Yescarta® CAR T-cell Therapy
1/30/2024
Kite, a Gilead Company (Nasdaq: GILD), today announced that the U.S. Food and Drug Administration (FDA) has approved a manufacturing process change resulting in a shorter manufacturing time for Yescarta® (axicabtagene ciloleucel). With this approval, Kite’s median turnaround time (TAT) in the U.S. is anticipated to be reduced from 16 days to 14 days. Median TAT is defined as time from leukapheresis, when a patient’s T cells are collected, to product release; manufacturing is
-
AbbVie Announces $223 Million Investment For New Biologics Manufacturing Facility In Singapore
1/29/2024
AbbVie (NYSE: ABBV) strengthened its manufacturing capabilities by breaking ground Thursday on a new US$223 million (S$301 million) expansion of its Singapore manufacturing facility. This new investment will add more than 100 jobs and new biologics manufacturing capacity to AbbVie's global network.
-
INTEPRHEX Puts Hot-Topic Science In 2024 Event Registration Now Open | Event Program Now Online
1/22/2024
The reimagined INTERPHEX Conference is designed to bring attendees together to solve their business challenges and to understand the science that is shaping their industries.
-
Cleanroom Leader AES Clean Technology Announces New Chief Revenue Officer
1/18/2024
A leading provider of high-performance cleanroom facilities, AES Clean Technology, has appointed Brian Weed as Chief Revenue Officer (CRO).
-
Single Use Support Continues To Grow, Expanding Its Team By 40%
1/17/2024
Innovative process solution provider Single Use Support continues to deliver strong organic growth, supported by an expansion in its employee base. With a successful year 2023 in the rear-view mirror, 2024 is already shaping up to be even better.
-
FUJIFILM Diosynth Biotechnologies And SHL Medical Enter Strategic Partnership Agreement To Help Meet Growing Market Demand For Autoinjector Medicines
1/8/2024
FUJIFILM Diosynth Biotechnologies, a world-leading contract development and manufacturing organization (CDMO) for biologics, vaccines, advanced therapies and oncolytic viruses today announced that it will expand its finished goods autoinjector services through a non-exclusive strategic partnership agreement with SHL Medical (SHL), a world-leading solutions provider of advanced drug delivery systems.
- Virtual Pharma Expo Announces 2024 Webinar Series Schedule 12/28/2023